Core Viewpoint - The company has received a patent for a novel taxane derivative and its preparation method, which will enhance its intellectual property protection and competitiveness in the market [1] Group 1: Patent Details - The patent is titled "A Taxane Derivative and Its Preparation Method, Application" with patent number ZL202311469030.2 [1] - The application date for the patent was November 7, 2023, and the authorization announcement date is December 16, 2025 [1] - The patent is valid for a period of 20 years [1] Group 2: Implications of the Patent - The invention can be utilized for impurity detection in taxane-based anticancer compounds, aiding in quality control [1] - While the patent will not have a significant impact on the company's recent operations, it contributes to the enhancement of the intellectual property protection system [1] - The patent is expected to improve the company's competitive edge in the industry [1]
吉贝尔:获得“一种紫杉烷衍生物及其制备方法、应用”发明专利